Developments Pentixapharm submits IND for hypertension diagnostic program Pentixapharm Holding (Frankfurt Prime Standard: PTP) announced the submission of an Investigational New Drug (IND) application to the FDA for its lead CXCR4-targeted diagnostic program in treatment resistant... May 11, 2026